Aptorum Group logo

Aptorum Group Share Price Today (NASDAQ: APM)

Aptorum Group share price is $0.94 & ₹80.69 as on 12 Jul 2025, 01.30 'hrs' IST

$0.94

0.01

(1.08%)

Market is closed - opens 7 PM, 14 Jul 2025

View live Aptorum Group share price in Dollar and Rupees. Guide to invest in Aptorum Group stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Aptorum Group, along with analyst recommendations, forecasts, and comprehensive financials.

Aptorum Group (APM) Key Statistics

in dollars & INR

Previous Close
$0.93
Open
$0.912
Market Capitalization
$6.6M
Today's Volume
$47.3K
Revenue TTM
$0.0
EBITDA
$-2.2M
Earnings Per Share (EPS)
$-0.78
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-30.62%

How to invest in Aptorum Group Stock (APM) from India?

It is very easy for Indian residents to invest directly in Aptorum Group from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Aptorum Group stock in both Indian Rupees (INR) and US Dollars (USD). Search for Aptorum Group or APM on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Aptorum Group or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Aptorum Group shares which would translate to 0.913 fractional shares of Aptorum Group as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India , including recognised companies like Aptorum Group, in just a few clicks!

Returns in Aptorum Group (APM) for Indian investors in Rupees

The Aptorum Group stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Aptorum Group investment value today

Current value as on today

₹23,539

Returns

₹76,461

(-76.46%)

Returns from Aptorum Group Stock

₹79,249 (-79.25%)

Dollar Returns*

₹2,789 (+2.79%)

Indian investors sentiment towards Aptorum Group (APM)

20%

Period: Jun 11, 2025 to Jul 11, 2025. Change in 30 Days versus previous period

Search interest for Aptorum Group Stock from India on INDmoney has increased by 20% in the last 30 days, reflecting an upward trend in search activity.

Global Institutional Holdings in Aptorum Group

  • Geode Capital Management, LLC

    0.52%

  • Morgan Stanley - Brokerage Accounts

    0.30%

  • Susquehanna International Group, LLP

    0.24%

  • XTX Topco Ltd

    0.14%

  • Advisor Group Holdings, Inc.

    0.08%

  • UBS Group AG

    0.05%

Analyst Recommendation on Aptorum Group

Rating
Trend

Buy

    83%Buy

    16%Hold

    0%Sell

Based on 6 Wall street analysts offering stock ratings for Aptorum Group(by analysts ranked 0 to 5 stars)

Analyst Forecast on Aptorum Group Stock (APM)

What analysts predicted

Upside of 8410.64%

Target:

$80.00

Current:

$0.94

Insights on Aptorum Group Stock (Ticker Symbol: APM)

  • Price Movement

    In the last 1 month, APM stock has moved down by -21.2%
  • APM vs ONC (1 yr)

    In the last 1 year, Beone Medicines Ltd has given 64.5% return, outperforming this stock by 144.0%
  • APM vs ALNY (3 yr)

    In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 40.1% return, outperforming this stock by 133.6%

Aptorum Group Technicals Summary

Sell

Neutral

Buy

Aptorum Group is currently in a neutral trading position according to technical analysis indicators.

Aptorum Group (APM) Vs Peers

Returns
Ratio's
Overview
Company Name1 Month6 Month1 Year3 Years5 Years
Aptorum Group Ltd logo
-21.19%
-30.08%
-79.47%
-93.54%
-97.15%
Regeneron Pharmaceuticals, Inc. logo
7.25%
-20.77%
-48.37%
-5.65%
-7.77%
Beone Medicines Ltd logo
-9.49%
35.57%
64.47%
47.45%
17.5%
Vertex Pharmaceuticals Incorporated logo
4.26%
13.39%
-4.1%
62.34%
64.57%
Alnylam Pharmaceuticals, Inc. logo
5.88%
21.8%
20.75%
120.43%
105.94%

About Aptorum Group

Aptorum Group Limited, through its subsidiaries, a clinical stage biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutic products to treat oncology and infectious diseases. Its pipeline products include SACT-1, a repurposed drug candidate, which is in phase 1 clinical trial to treat neuroblastoma and other cancer types; ALS-4, a repurposed small molecule, which is in phase 1 clinical trial for the treatment of bacterial infections, such as staphylococcus aureus, mycobacterium tuberculosis, and pseudomonas aeruginosa; and RPIDD, a liquid biopsy rapid pathogen diagnostic which is in preclinical trial to treat pathogen molecular diagnostics. The company also develops SACT-COV19, a repurposed small molecule which is in preclinical trial for the treatment of coronavirus disease; SACT-2 and SACT-3; ALS-1, a small molecule which is in preclinical trial to treat bacterial infections caused by staphylococcus aureus, including methicillin-resistant staphylococcus aureus (MRSA); and ALS-2/3, a small molecule which is in preclinical trial for the treatment of gram+ve bacterial infections. In addition, it is developing NLS-1, which is in preclinical trial for the treatment of endometriosis; DLS-1+2, which is in preclinical trial to treat NSCLC with mutation; DLS-3, which is in preclinical trial to treat autoimmune disease; CLS-1, a macromolecule, which is in preclinical trial to treat obesity; and CLS-1 and CLS-3. Further, the company offers NativusWell DOI (NLS-2), a dietary supplement for women undergoing menopause; and provides management services. The company was formerly known as APTUS Holdings Limited and changed its name to Aptorum Group Limited in October 2017. Aptorum Group Limited was incorporated in 2010 and is headquartered in London, the United Kingdom.
Organization
Aptorum Group
Employees
1
CEO
Mr. Chung Yuen Huen
Industry
Health Technology

Management People of Aptorum Group

NameTitle
Mr. Chung Yuen Huen
Founder, CEO & Executive Director
Mr. Kwok Kuen Wong
Head of Finance

Important FAQs about investing in APM Stock from India :

Can Indians buy Aptorum Group shares?

Yes, Indians can invest in the Aptorum Group (APM) from India.

With INDmoney, you can buy Aptorum Group at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Aptorum Group at zero transaction cost.

How can I buy Aptorum Group shares from India?

It is very easy to buy Aptorum Group from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Aptorum Group (APM) be purchased?

Yes, you can buy fractional shares of Aptorum Group with INDmoney app.

What are the documents required to start investing in Aptorum Group stocks?

To start investing in Aptorum Group, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What is Aptorum Group share price today?

Aptorum Group share price today stands at $0.94, Open: $0.91 ; Previous Close: $0.93 ; High: {{1_rba_end}} ; Low: {{1_rba_st}} ; 52 Week High: {{rba_end}} ; 52 Week Low: {{rba_st}}.

The stock opens at $0.91, after a closing price of $0.93. The stock reached a daily high of {{1_rba_end}} and a low of {{1_rba_st}}, with a 52-week high of {{rba_end}} and a 52-week low of {{rba_st}}.

What are today’s High and Low prices of Aptorum Group Stock (APM)?

Today’s highest price of Aptorum Group (APM) is {{1_rba_end}}.

Today’s lowest price of Aptorum Group (APM) is {{1_rba_st}}.

What is the 52 Week High and Low Range of Aptorum Group Stock (APM)?

  • 52 Week High

    {{rba_end}}

  • 52 Week Low

    {{rba_st}}

What are the historical returns of Aptorum Group (APM)?

  • 1 Month Returns

    -21.19%

  • 3 Months Returns

    -30.08%

  • 1 Year Returns

    -79.47%

  • 5 Years Returns

    -97.15%

What is today's market capitalisation of Aptorum Group?

Today's market capitalisation of Aptorum Group APM is 6.6M

Who is the Chief Executive Officer (CEO) of Aptorum Group ?

Mr. Chung Yuen Huen is the current Chief Executive Officer (CEO) of Aptorum Group.